Clinical Trial Update: Vildagliptin vs Sitagliptin add-on to Insulin - Impact on Glycemic Profile and Correlation of Hypoglycemic Episodes and Heart Function [Phase 4]

View source ↗

Summary

This Phase 4 trial compares vildagliptin versus sitagliptin added to insulin in type 2 diabetes, assessing changes in glycemic profile and the relationship betw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Galvus (vildagliptin)
• Januvia (sitagliptin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Diabetes Mellitus Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2015-10-02